Representative Kevin Hern (Republican-Oklahoma) recently sold shares of STERIS plc (NYSE:STE). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in STERIS stock on September 15th. The trade occurred in the Representative’s “KEVIN HERN TRADITIONAL IRA” account.
Representative Kevin Hern also recently made the following trade(s):
- Sold $15,001 – $50,000 in shares of CenterPoint Energy (NYSE:CNP) on 9/15/2026.
- Sold $1,001 – $15,000 in shares of TJX Companies (NYSE:TJX) on 9/15/2026.
- Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 9/15/2026.
- Sold $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 9/14/2026.
- Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of IQVIA (NYSE:IQV) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
- Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of Emerson Electric (NYSE:EMR) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of Devon Energy (NYSE:DVN) on 9/14/2026.
STERIS Trading Down 1.1%
Shares of NYSE:STE traded down $2.40 during midday trading on Tuesday, reaching $208.60. 52,162 shares of the company’s stock were exchanged, compared to its average volume of 769,133. The stock has a market cap of $20.34 billion, a price-to-earnings ratio of 25.55 and a beta of 0.91. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44. The firm’s 50 day simple moving average is $224.38 and its two-hundred day simple moving average is $218.45. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.91 and a quick ratio of 1.35.
STERIS Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Friday, September 4th were given a $0.69 dividend. This is an increase from STERIS’s previous quarterly dividend of $0.63. This represents a $2.76 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date was Friday, September 4th. STERIS’s dividend payout ratio (DPR) is presently 33.74%.
Insiders Place Their Bets
In other STERIS news, Director Mohsen Sohi sold 4,058 shares of the business’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total transaction of $956,795.24. Following the transaction, the director owned 24,305 shares in the company, valued at $5,730,632.90. The trade was a 14.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.12% of the company’s stock.
Hedge Funds Weigh In On STERIS
Institutional investors have recently modified their holdings of the company. Sequoia Financial Advisors LLC increased its stake in STERIS by 8.3% in the second quarter. Sequoia Financial Advisors LLC now owns 30,305 shares of the medical equipment provider’s stock valued at $6,381,000 after purchasing an additional 2,324 shares during the last quarter. Engineers Gate Manager LP purchased a new position in STERIS in the second quarter valued at approximately $2,000,000. NewEdge Advisors LLC lifted its position in STERIS by 0.7% during the second quarter. NewEdge Advisors LLC now owns 8,118 shares of the medical equipment provider’s stock valued at $1,710,000 after buying an additional 56 shares in the last quarter. Squarepoint Ops LLC grew its stake in STERIS by 1,373.7% during the second quarter. Squarepoint Ops LLC now owns 41,898 shares of the medical equipment provider’s stock worth $8,822,000 after buying an additional 39,055 shares during the period. Finally, Allworth Financial LP raised its stake in shares of STERIS by 7.7% in the 2nd quarter. Allworth Financial LP now owns 1,843 shares of the medical equipment provider’s stock valued at $388,000 after acquiring an additional 132 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.
Analyst Ratings Changes
STE has been the topic of several research reports. Weiss Ratings reissued a “hold (c)” rating on shares of STERIS in a research note on Monday, August 24th. UBS Group reduced their price target on shares of STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research report on Friday, August 7th. Wall Street Zen upgraded shares of STERIS from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Finally, Piper Sandler reiterated an “overweight” rating and set a $275.00 target price (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, STERIS has a consensus rating of “Moderate Buy” and an average price target of $271.33.
Read Our Latest Research Report on STERIS
About Representative Hern
Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.
Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.
Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.
About STERIS
STERIS plc (NYSE: STE) is a global provider of products and services designed to support infection prevention, sterilization, surgical procedures and other critical healthcare and life sciences activities. The company serves hospitals, ambulatory surgery centers, dental practices, pharmaceutical and biotechnology manufacturers, medical device companies, and research organizations.
Its offerings include sterilizers, washers, surgical tables and lights, operating-room equipment, endoscopy products, infection-prevention consumables, and related maintenance and technical services.
Featured Stories
- Five stocks we like better than STERIS
- Why SpaceX Investors Should Look Past Starship’s Fiery Splashdown
- Meta’s Muse Is Taking Aim at E-Commerce, But Amazon Isn’t Playing Along
- NVIDIA Just Strengthened the Case for Its Massive Stock Price Upside
- Apple, Meta, and SpaceX Are Driving a Device Boom—These 3 Stocks Could Benefit
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
